NCT04340596 · Interventional trial
Safety, Tolerability, and Efficacy of IL-15 Superagonist (N-803) With and Without Combination Broadly Neutralizing Antibodies to Induce HIV-1 Control During Analytic Treatment Interruption
Overall registry status Active not recruiting
Phase 1
Conditions HIV Infection
Delaware Valley sites
- Penn Therapeutics, CRS (Site ID: 6201) · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory